Related references
Note: Only part of the references are listed.Home Time Is Extended in Patients With Ischemic Stroke Who Receive Thrombolytic Therapy A Validation Study of Home Time as an Outcome Measure
Nishant K. Mishra et al.
STROKE (2011)
Comparison of Outcomes Following Thrombolytic Therapy Among Patients With Prior Stroke and Diabetes in the Virtual International Stroke Trials Archive (VISTA)
N. K. Mishra et al.
DIABETES CARE (2010)
VISTA-Rehab: A resource for stroke rehabilitation trials
Myzoon Ali et al.
INTERNATIONAL JOURNAL OF STROKE (2010)
The Virtual International Stroke Trials Archive (VISTA): results and impact on future stroke trials and management of stroke patients
C. Weimar et al.
INTERNATIONAL JOURNAL OF STROKE (2010)
Thrombolysis Is Associated With Consistent Functional Improvement Across Baseline Stroke Severity A Comparison of Outcomes in Patients From the Virtual International Stroke Trials Archive (VISTA)
Nishant K. Mishra et al.
STROKE (2010)
Thrombolysis in very elderly people: controlled comparison of SITS International Stroke Thrombolysis Registry and Virtual International Stroke Trials Archive
Nishant K. Mishra et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Ralph L. Sacco et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke
Werner Hacke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
The virtual international stroke trials archive
Myzoon Ali et al.
STROKE (2007)
Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials
Katayoun Vahedi et al.
LANCET NEUROLOGY (2007)
Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
DL Bhatt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Impracticability of informed consent in the Registry of the Canadian Stroke Network
JV Tu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial
HC Diener et al.
LANCET (2004)
The price of innovation: new estimates of drug development costs
JA DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2003)
Share Paper
